The shares of MKS Instruments, Inc. (NASDAQ:MKSI) started off the last trading session with the price of $125.55 while closing the day with the price of $125.15. The shares of MKS Instruments, Inc. (NASDAQ:MKSI) Rise 0.24% with the Loss of -0.4 points.
The shares of MKS Instruments, Inc. (NASDAQ:MKSI) traded with the day volume of 384806 shares whereas its average trading volume is 545.27 Million.
While analyzing the past performance of the stock we can see that the shares of MKS Instruments, Inc. (NASDAQ:MKSI) Gain 9.3% in the last week while rising 28.95% in the last month. Past quarter performance shows the green light with 30.64%. The semi-annual and annual performance shows 51.7% and 89.05% respectively.
Some critical values of the shares of MKS Instruments, Inc. (NASDAQ:MKSI) to be discussed here are: the beta which shows the value at 0.96 while Average True Range of MKS Instruments, Inc. (NASDAQ:MKSI) demonstrate the value at 4.36. The weekly and monthly volatility of the shares of MKS Instruments, Inc. (NASDAQ:MKSI) are indicated at 2.96% and 3.83%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 74.41.
While studying the financial position of the shares of MKS Instruments, Inc. (NASDAQ:MKSI), we can see that the Market capitalization of the company is at 6.8 Billion. The shares outstanding for the company is 54.32 Million and the shares float stands at 53.41 Million. The income of the company stand at 357.3 Million while the sales stand at 1.92 Billion.
Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 6.49, Price to Earnings or P/E is at 19.29, Price to Sales P/S show the value of 3.55, the Return on Asset ROA stood at 0.144 and the Return on Equity ROE depicted at 0.233 while Return on Investment ROI is at 0.197.
Akebia Therapeutics, Inc. (NASDAQ:AKBA)
Akebia Therapeutics, Inc. (NASDAQ:AKBA) started its previous trading session at $14.12 and closed at $13.52 showing a Fell of -3.98 Percent.
The Company traded with an average Volume of 314.58 Million whereas, its Day Volume stood at 384143.
Looking at the performance of the stock, Akebia Therapeutics, Inc. (NASDAQ:AKBA) Loss -5.72% in the last week in its shares price and -3.43% in the last month. Quarterly performance shows a red of -12.77 Percent while Semi-Annual and Annual performances shows a -19.43 and 45.69 percent respectively.
Beta for Akebia Therapeutics, Inc. (NASDAQ:AKBA) stands at 0.79 while the ATR (average true range) is at 0.64. The Stock’s Weekly and Monthly Volatility is 5.05% and 4.67% respectively showing a RSI value of 39.49.
While studying the financial position of the shares of Akebia Therapeutics, Inc. (NASDAQ:AKBA), we can see that the Market capitalization of the company is at 617.32 Million. The shares outstanding for the company is 45.66 Million and the shares float stands at 37.82 Million.
The Company generated an income of -127100000 and the sales of 92.2 Million in the Trailing Twelve Months period.
While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-3.16 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 6.7 respectively.
The Return on Assets stands at -0.412, ROE shows a value of -1.988 and ROI for Akebia Therapeutics, Inc. (NASDAQ:AKBA) is -2.004 as of Trailing Twelve Months period.
